Announcement Summary
Entity name
CRESO PHARMA LIMITED
Announcement Type New announcement
Date of this announcement Friday April 01, 2022
Details of +securities that have ceasedASX +security codeSecurity descriptionNumber of +securities that The +securities have have ceased ceased due to
Date of cessation
CPHAV
OPTION EXPIRING 10-MAR-2024 EX 8C
333,334 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied
CPHAW
OPTION EXPIRING 10-MAR-2024 EX 16C
333,334 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied
CPHAX
OPTION EXPIRING 10-MAR-2024 EX 20CRefer to next page for full details of the announcement
166,667 Lapse of conditional right to 31/03/2022 securities because the conditions have not been, or have become incapable of being, satisfied
Part 1 - Announcement Details
1.1 Name of +Entity CRESO PHARMA LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type ABN
1.3 ASX issuer code CPH
1.4 The announcement isNew announcement
1.5 Date of this announcement 1/4/2022
Registration Number 89609406911
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
CPHAV : OPTION EXPIRING 10-MAR-2024 EX 8C
Unquoted +equity securities that have ceased
Number of securities that have ceased 333,334
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied
Date of cessation 31/3/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
N/A
ASX +Security Code and Description
CPHAW : OPTION EXPIRING 10-MAR-2024 EX 16C
Unquoted +equity securities that have ceased
Number of securities that have ceased 333,334
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied
Date of cessation 31/3/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
N/A
ASX +Security Code and Description
CPHAX : OPTION EXPIRING 10-MAR-2024 EX 20C
Unquoted +equity securities that have ceased
Number of securities that have ceased
Number of securities that have ceased 166,667
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied
onlyFor personal use
Date of cessation 31/3/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
N/A
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)Total number of
ASX +security code and description | +securities on issue |
CPHOA : OPTION EXPIRING 22-JAN-2023 | 63,958,997 |
CPH : ORDINARY FULLY PAID | 1,296,092,502 |
CPHO : OPTION EXPIRING 02-NOV-2024 | 400,942,239 |
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)ASX +security code and descriptionTotal number of
+securities on issue
CPHAAN : OPTION EXPIRING 06-SEP-2024 EX $0.25 10,000,000
CPHAAO : PERFORMANCE RIGHTS 15,000,000
CPHAY : OPTION EXPIRING 02-JUN-2023 EX 17C 27,764,706
CPHAAA : OPTION EXPIRING 02-JUN-2023 EX 20C 8,000,000
CPHAZ : OPTION EXPIRING 02-JUN-2023 EX 25C 4,000,000
CPHAQ : OPTION EXPIRING 15-SEP-2022 EX 80C
300,000
CPHAAB : OPTION EXPIRING 25-JUN-2023 EX 13.86C 5,752,688
CPHAAL : OPTION EXPIRING 01-AUG-2024 EX $0.18 12,000,000
CPHAS : OPTION EXPIRING 12-FEB-2023 EX 40C 6,847,725
CPHAT : OPTION EXPIRING 12-FEB-2023 EX 35C 2,128,387
CPHAAK : OPTION EXPIRING 01-AUG-2024 EX $0.15 12,000,000
CPHAAM : OPTION EXPIRING 06-SEP-2024 EX $0.18 10,000,000
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Creso Pharma Ltd. published this content on 01 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2022 06:12:04 UTC.